Drug
Ims001
Ims001: highest development phase Phase 1, developed by Zhuhai Hengqin ImStem Biotechnology Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Zhuhai Hengqin ImStem Biotechnology Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| IMS001 NCT07935031 | Phase 1 | Multiple Sclerosis |
Latest
No recent events.
Follow Ims001 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.